Thomas Reiser/LinkedIn
Nov 20, 2025, 13:42
Rebalancing Therapies Poised to Transform Hemophilia Care․ Explore the New ISTH CME
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on X:
” New ISTH CME activity available:
Rebalancing Therapies for Hemophilia Are You Ready?
Gain the latest insights on emerg. rebalancing treatments, compare evolving clin. profiles & learn how to prepare your team for what’s next in hemophilia care.”
Read more here.
Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis